Clinical Trials Directory

Trials / Completed

CompletedNCT00508482

A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
475 (actual)
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to re-evaluate the therapeutic superiority and safety of acupuncture treatment using high quality and large sampled clinical research. The investigators want to provide a preferred treatment protocol, which is effective, safe, and easy to use in clinical practice. This research also clarifies that the insertion depth is a key factor in the therapeutic effect of acupuncture. The results of the study will help promote the development of the standardization of acupuncture.

Detailed description

Functional constipation is a high morbidity disease. The life-long treatment of functional constipation can seriously impact a patient's quality of life. At present, one of the most frequently used treatment is catharsis, which deals with the symptom. There are three main problems with catharsis. First, there are no long-lasting effects once the patient stops taking medication. Second, there are many side effects, including abdominal pain with defecation and diarrhea. Third, long-term use of irritant laxatives will not only make the constipation become refractory and complex; but also, this type of medicine can harm the enteric nervous system, cause melanosis coli, or even carcinoma of colon. Therefore, a therapy that is safe with minimal side effects and good short-term and long-term effects is urgently needed in functional constipation treatment. Clinical practice shows that acupuncture may meets this need to some extent. The acupuncture therapy is safe and effective and the therapeutic effects are still present several months after the treatment has been completed.

Conditions

Interventions

TypeNameDescription
OTHERdeep needlingHuatuo brand needle (0.35×75mm), LH202H electric stimulator, parameter is constant wave, 2/15Hz, and current intensity is the abdominal muscles shiver slightly and the patient feels trivial pain. Once a day, five times a week, four weeks.
DRUGLactulose20-30ml, once a day before breakfast, for the whole study except the run-in period
OTHERshallow needlingHuatuo brand needle (0.30×25mm). The usage of EA apparatus and treatment course were the same as deep needling group.

Timeline

Start date
2008-04-01
Primary completion
2011-09-01
Completion
2011-11-01
First posted
2007-07-30
Last updated
2014-06-04
Results posted
2013-03-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00508482. Inclusion in this directory is not an endorsement.